{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T18:18:31Z","timestamp":1763057911928},"reference-count":14,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"vor","delay-in-days":366,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Investigative Dermatology Symposium Proceedings"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1038\/jidsymp.2015.33","type":"journal-article","created":{"date-parts":[[2015,11,13]],"date-time":"2015-11-13T09:21:14Z","timestamp":1447406474000},"page":"16-18","source":"Crossref","is-referenced-by-count":6,"title":["Diphencyprone Treatment of Alopecia Areata: Postulated Mechanism of Action and Prospects for Therapeutic Synergy with RNA Interference"],"prefix":"10.1016","volume":"17","author":[{"given":"Karen G.","family":"Bulock","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James P.","family":"Cardia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pamela A.","family":"Pavco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William R.","family":"Levis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/jidsymp.2015.33_bb0010","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1468-3083.2007.02411.x","article-title":"Alopecia areata: topical immunotherapy treatment with diphencyprone","volume":"22","author":"Avgerinou","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1038\/jidsymp.2015.33_bb0015","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1089\/jop.2013.0148","article-title":"Novel hydrophobically modified assymetric RNAi compounds (sd-rxRNA) demonstrate robust efficacy in the eye","volume":"10","author":"Byrne","year":"2013","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1038\/jidsymp.2015.33_bb0020","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.jaad.2014.04.036","article-title":"Clinical efficacy of diphenylcyclopropenone in alopecia areata: retrospective data analysis of 50 patients","volume":"71","author":"Chiang","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1038\/jidsymp.2015.33_bb0025","first-page":"5365","article-title":"Suppression of OCT4B enhances sensitivity of lung adenocarcinoma A549 cells to cisplatin via increased apoptosis","volume":"33","author":"Cortes-Dericks","year":"2013","journal-title":"Anticancer Res"},{"key":"10.1038\/jidsymp.2015.33_bb0030","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1067\/mjd.2001.109309","article-title":"The use of topical diphenylcyclopropenone for the treatment of extensive alopecia areata","volume":"44","author":"Cotellessa","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1038\/jidsymp.2015.33_bb0035","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/jso.23506","article-title":"Topical immunotherapy with diphencyprone for in transit and cutaneously metastatic melanoma","volume":"109","author":"Damian","year":"2014","journal-title":"J Surg Oncol"},{"key":"10.1038\/jidsymp.2015.33_bb0040","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1038\/jid.2014.196","article-title":"Molecular characterization of human skin response to diphencyprone at peak and resolution phases: therapeutic insights","volume":"134","author":"Gulati","year":"2014","journal-title":"J Investig Dermatol Symp Proc"},{"key":"10.1038\/jidsymp.2015.33_bb0045","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2340\/00015555634952","article-title":"Diphencyprone in the treatment of alopecia areata","volume":"63","author":"Happle","year":"1983","journal-title":"Acta Derm Venereol"},{"key":"10.1038\/jidsymp.2015.33_bb0050","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jdermsci.2008.04.003","article-title":"Therapeutic siRNAs for dominant genetic skin disorders including pachyonychia congenital","volume":"51","author":"Leachman","year":"2008","journal-title":"J Dermatol Sci"},{"key":"10.1038\/jidsymp.2015.33_bb0055","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1468-3083.2011.04114.x","article-title":"Topical immunotherapy with diphenylcyclopropenone of patients with alopecia areata\u2014a large retrospective study on 142 patients with a self-controlled design","volume":"26","author":"Ohlmeier","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1038\/jidsymp.2015.33_bb0060","doi-asserted-by":"crossref","first-page":"628","DOI":"10.4065\/70.7.628","article-title":"Incidence of alopecia areata in Olmsted County, Minnesota 1975\u20131989","volume":"70","author":"Safavi","year":"1995","journal-title":"Mayo Clin Proc"},{"key":"10.1038\/jidsymp.2015.33_bb0065","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s10549-011-1409-2","article-title":"Enhancement of chemotherapeutic efficacy in hypermethylator breast cancer cells through targeted and pharmacologic inhibition of DNMT3b","volume":"131","author":"Sandhu","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"10.1038\/jidsymp.2015.33_bb0070","doi-asserted-by":"crossref","first-page":"e567","DOI":"10.1111\/ijd.12688","article-title":"Investigations of the efficacy of diphenylcyclopropenone immunotherapy for the treatment of warts","volume":"53","author":"Suh","year":"2014","journal-title":"Int J Dermatol"},{"key":"10.1038\/jidsymp.2015.33_bb0075","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/nm.3645","article-title":"Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition","volume":"20","author":"Xing","year":"2014","journal-title":"Nat Med"}],"container-title":["Journal of Investigative Dermatology Symposium Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1087002416300338?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1087002416300338?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T12:27:05Z","timestamp":1718195225000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1087002416300338"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":14,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S1087002416300338"],"URL":"https:\/\/doi.org\/10.1038\/jidsymp.2015.33","relation":{},"ISSN":["1087-0024"],"issn-type":[{"value":"1087-0024","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]}}}